Your browser doesn't support javascript.
loading
Therapeutic effects of the novel subtype-selective histone deacetylase inhibitor chidamide on myeloma-associated bone disease.
He, Jingsong; Chen, Qingxiao; Gu, Huiyao; Chen, Jing; Zhang, Enfan; Guo, Xing; Huang, Xi; Yan, Haimeng; He, DongHua; Yang, Yang; Zhao, Yi; Wang, Gang; He, Huang; Yi, Qing; Cai, Zhen.
Affiliation
  • He J; Bone Marrow Transplantation Center, Department of Hematology, The First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, China.
  • Chen Q; Bone Marrow Transplantation Center, Department of Hematology, The First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, China.
  • Gu H; Bone Marrow Transplantation Center, Department of Hematology, The First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, China.
  • Chen J; Bone Marrow Transplantation Center, Department of Hematology, The First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, China.
  • Zhang E; Bone Marrow Transplantation Center, Department of Hematology, The First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, China.
  • Guo X; Bone Marrow Transplantation Center, Department of Hematology, The First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, China.
  • Huang X; Bone Marrow Transplantation Center, Department of Hematology, The First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, China.
  • Yan H; Bone Marrow Transplantation Center, Department of Hematology, The First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, China.
  • He D; Bone Marrow Transplantation Center, Department of Hematology, The First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, China.
  • Yang Y; Bone Marrow Transplantation Center, Department of Hematology, The First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, China.
  • Zhao Y; Bone Marrow Transplantation Center, Department of Hematology, The First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, China.
  • Wang G; Bone Marrow Transplantation Center, Department of Hematology, The First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, China.
  • He H; Quzhou People's Hospital, Zhejiang Province, China.
  • Yi Q; Bone Marrow Transplantation Center, Department of Hematology, The First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, China.
  • Cai Z; Department of Cancer Biology, Lerner Research Institute, Cleveland Clinic, OH, USA.
Haematologica ; 103(8): 1369-1379, 2018 08.
Article in En | MEDLINE | ID: mdl-29773595
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Benzamides / Bone Diseases / Histone Deacetylase Inhibitors / Aminopyridines / Multiple Myeloma Type of study: Etiology_studies / Prognostic_studies / Risk_factors_studies Limits: Animals / Humans Language: En Journal: Haematologica Year: 2018 Type: Article Affiliation country: China
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Benzamides / Bone Diseases / Histone Deacetylase Inhibitors / Aminopyridines / Multiple Myeloma Type of study: Etiology_studies / Prognostic_studies / Risk_factors_studies Limits: Animals / Humans Language: En Journal: Haematologica Year: 2018 Type: Article Affiliation country: China